Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities.
In prostate cancer, two different types of histone lysine demethylases (KDM), LSD1/KDM1 and JMJD2/KDM4, are coexpressed and colocalize with the androgen receptor. We designed and synthesized hybrid LSD1/JmjC or "pan-KDM" inhibitors 1-6 by coupling the skeleton of tranylcypromine 7, a known...
Main Authors: | Rotili, D, Tomassi, S, Conte, M, Benedetti, R, Tortorici, M, Ciossani, G, Valente, S, Marrocco, B, Labella, D, Novellino, E, Mattevi, A, Altucci, L, Tumber, A, Yapp, C, King, O, Hopkinson, R, Kawamura, A, Schofield, C, Mai, A |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2014
|
פריטים דומים
-
A miniaturized screen for inhibitors of Jumonji histone demethylases.
מאת: Sakurai, M, et al.
יצא לאור: (2010) -
A miniaturized screen for inhibitors of Jumonji histone demethylases.
מאת: Sakurai, M, et al.
יצא לאור: (2010) -
Targeting histone lysine demethylases - Progress, challenges, and the future.
מאת: Thinnes, C, et al.
יצא לאור: (2014) -
Chemical probes for histone lysine demethylases
מאת: Gerken, P
יצא לאור: (2016) -
A selective inhibitor and probe of the cellular functions of Jumonji C domain-containing histone demethylases.
מאת: Luo, X, et al.
יצא לאור: (2011)